Our study provides valuable insights into the genetic landscape of CSF3R-mutated myeloid neoplasm and adds to the growing body of evidence that CSF3R mutations, especially T618I, are a critical component of the molecular landscape beyond CNL, aCML, and SCN. This evidence concerns the gene CSF3R and severe congenital neutropenia.